Drugmaker Ranbaxy Laboratories Ltd has received approval from the US FDA to sell the generic version of Aricept, a drug for treating Alzheimer's disease, with the US. But is the Aricept approval any indication that Ranbaxy could be headed for a resolution of their FDA issues?
